Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: A population-based study

被引:83
作者
Baser, ME
Kuramoto, L
Joe, H
Friedman, JM
Wallace, AJ
Gillespie, JE
Ramsden, RT
Evans, DGR
机构
[1] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada
[2] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1W5, Canada
[3] Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England
[4] Manchester Royal Infirm, Dept Radiol, Manchester M13 9WL, Lancs, England
[5] Manchester Royal Infirm, Dept Otolaryngol, Manchester M13 9WL, Lancs, England
关键词
D O I
10.1086/422700
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Neurofibromatosis 2 (NF2) is an autosomal dominant disease that is characterized by tumors on the vestibular branch of the VIII cranial nerve, but other types of nervous system tumors usually occur as well. Genotype-phenotype correlations are well documented for overall NF2 disease severity but have not been definitively evaluated for specific types of non - VIII nerve tumors. We evaluated genotype-phenotype correlations for various types of non - VIII nerve tumors in 406 patients from the population-based United Kingdom NF2 registry, using regression models with the additional covariates of current age and type of treatment center (specialty or nonspecialty). The models also permitted consideration of intrafamilial correlation. We found statistically significant genotype-phenotype correlations for intracranial meningiomas, spinal tumors, and peripheral nerve tumors. People with constitutional NF2 missense mutations, splice-site mutations, large deletions, or somatic mosaicism had significantly fewer tumors than did people with constitutional nonsense or frameshift NF2 mutations. In addition, there were significant intrafamilial correlations for intracranial meningiomas and spinal tumors, after adjustment for the type of constitutional NF2 mutation. The type of constitutional NF2 mutation is an important determinant of the number of NF2-associated intracranial meningiomas, spinal tumors, and peripheral nerve tumors.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 48 条
[1]   Genotype-phenotype correlations for cataracts in neurofibromatosis 2 [J].
Baser, ME ;
Kuramoto, L ;
Joe, H ;
Friedman, JM ;
Wallace, AJ ;
Ramsden, RT ;
Evans, DGR .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (10) :758-760
[2]   Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2 [J].
Baser, ME ;
Makariou, EV ;
Parry, DM .
JOURNAL OF NEUROSURGERY, 2002, 96 (02) :217-222
[3]   Predictors of the risk of mortality in neurofibromatosis 2 [J].
Baser, ME ;
Friedman, JM ;
Aeschliman, D ;
Joe, H ;
Wallace, AJ ;
Ramsden, RT ;
Evans, DGR .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) :715-723
[4]   High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH [J].
Bruder, CEG ;
Hirvelä, C ;
Tapia-Paez, I ;
Fransson, I ;
Segraves, R ;
Hamilton, G ;
Zhang, XX ;
Evans, DG ;
Wallace, AJ ;
Baser, ME ;
Zucman-Rossi, J ;
Hergersberg, M ;
Boltshauser, E ;
Papi, L ;
Rouleau, GA ;
Poptodorov, G ;
Jordanova, A ;
Rask-Andersen, H ;
Kluwe, L ;
Mautner, V ;
Sainio, M ;
Hung, G ;
Mathiesen, T ;
Möller, C ;
Pulst, SM ;
Harder, H ;
Heiberg, A ;
Honda, M ;
Miimura, M ;
Sahlén, S ;
Blennow, E ;
Albertson, DG ;
Pinkel, D ;
Dumanski, JP .
HUMAN MOLECULAR GENETICS, 2001, 10 (03) :271-282
[5]  
Bruder CEG, 1999, GENE CHROMOSOME CANC, V25, P184, DOI 10.1002/(SICI)1098-2264(199906)25:2<184::AID-GCC15>3.0.CO
[6]  
2-B
[7]  
Evans DA, 1998, KLUW S INF, V2, P63
[8]   A GENETIC-STUDY OF TYPE-2 NEUROFIBROMATOSIS IN THE UNITED-KINGDOM .1. PREVALENCE, MUTATION-RATE, FITNESS, AND CONFIRMATION OF MATERNAL TRANSMISSION EFFECT ON SEVERITY [J].
EVANS, DGR ;
HUSON, SM ;
DONNAI, D ;
NEARY, W ;
BLAIR, V ;
TEARE, D ;
NEWTON, V ;
STRACHAN, T ;
RAMSDEN, R ;
HARRIS, R .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (12) :841-846
[9]   Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations [J].
Evans, DGR ;
Trueman, L ;
Wallace, A ;
Collins, S ;
Strachan, T .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (06) :450-455
[10]  
EVANS DGR, 1992, Q J MED, V84, P603